US News and World Report has ranked the UC Berkeley-UCSF Graduate Program in Bioengineering FOURTH among bioengineering graduate programs in the US. This is up two places from the previous year. Go BioE!
Professor Amy Herr and her lab are highlighted in this Nature Methods Technology Feature, exploring new ways to for researchers to share designs, devices and experience.
Greg Wohlleb MEng ’16 (BIOE) returned in February 2018 to represent BD Biosciences, chat with students about his work in engineering, and share his advice for getting the job.
Professors Sanjay Kumar and Kevin Healy, in collaboration with Professor of Nutritional Sciences and Toxicology Andreas Stahl, have discovered that the same kind of fat cells that help newborn babies regulate their body temperature could be a target for weight-loss drugs in adults.
Synthetic biology startup Senti Bio, co-founded by PhD alumnus Philip Lee, has now raised $53 million in investments to fund their development of a design platform for synthetic gene circuits that can rapidly design, build, and test various therapeutic circuits.
Boost Biomes’ proprietary DNA sequencing-based discovery platform was developed by the company’s cofounders, biotechnology veterans Rob McBride, Jamie Bacher and Adam Arkin, to identify commercially viable microbial products. Boost Biomes’ first two products are focused on improving yield in the field and reducing spoilage after harvest, and are being evaluated in commercially relevant trials.
Associate Teaching Professor Terry Johnson has been identified as one of the 10 Best Professors at UC Berkeley by College Magazine.
PhD student Thomas Carey was selected as the winner of the Diagnostics World Early Innovator Awards program at the 2018 Molecular Medicine Tri Conference in San Francisco. Carey and his colleagues are developing a low-cost microfluidic-based platform to detect the presence of biomarkers present in virtually every fluid.
Master of Engineering students Jasodhara Raj (BIOE), Suyasha Gupta (BIOE), and Arnaud Bard de Coutance (ME) aim to develop software to automate and standardize the reporting procedures for influenza cases. This would mean that hospitals and physicians do not have to report data themselves, which would save a significant amount of time and increase physicians’ incentives to run the tests leading to improvement in tracking.